speb/financial-data huggingface dataset:
IVX.AX income_statement (annual, 2023-06-30) — Operating Revenue: 4104711.00
IVX.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 64216322.00
IVX.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 1988269.00
IVX.AX income_statement (annual, 2023-06-30) — Other Gand A: 492095.00
IVX.AX balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 13227846.00
IVX.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 1916081.00
IVX.AX balance_sheet (annual, 2023-06-30) — Other Payable: 187472.00
IVX.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 14113.00
IVX.AX balance_sheet (annual, 2023-06-30) — Payables: 587243.00
IVX.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 587243.00
IVX.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -4898665.00
IVX.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 63382.00
IVX.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 59874.00
IVX.AX income_statement (annual, 2023-06-30) — Pretax Income: -1614823.00
IVX.AX cash_flow (annual, 2023-06-30) — Purchase Of Intangibles: -2500000.00
IVX.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -75832.00
IVX.AX cash_flow (annual, 2023-06-30) — Receiptsfrom Customers: 3066424.00
IVX.AX balance_sheet (annual, 2023-06-30) — Receivables: 1615723.00
IVX.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 683107.00
IVX.AX income_statement (annual, 2023-06-30) — Rent And Landing Fees: 43600.00
IVX.AX income_statement (annual, 2023-06-30) — Research And Development: 1537011.00
IVX.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -130475224.00
IVX.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 1081290.00
IVX.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 1616985.00
IVX.AX balance_sheet (annual, 2023-06-30) — Share Issued: 64216322.00
IVX.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 18396204.00
IVX.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 5168358.00
IVX.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
IVX.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
IVX.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
IVX.AX balance_sheet (annual, 2023-06-30) — Total Assets: 19046829.00
IVX.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 18396204.00
IVX.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 18396204.00
IVX.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 650625.00
IVX.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 13286329.00
IVX.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
IVX.AX balance_sheet (annual, 2023-06-30) — Working Capital: 5109875.00
IVX.AX income_statement (annual, 2024-06-30) — +Operating Expense: 9131458.00
IVX.AX income_statement (annual, 2024-06-30) — +Total Revenue: 3694256.00
IVX.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 720948.00
IVX.AX income_statement (annual, 2024-06-30) — Amortization: 797004.00
IVX.AX income_statement (annual, 2024-06-30) — Amortization Of Intangibles Income Statement: 797004.00
IVX.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 64244070.00
IVX.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.09
IVX.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 4084903.00
IVX.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -900000.00
IVX.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 148354600.00
IVX.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 783526.00
IVX.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 783526.00
IVX.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 783526.00
IVX.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -900000.00
IVX.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2401377.00
IVX.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -3301377.00
IVX.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -4064927.00
IVX.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 1600000.00
IVX.AX balance_sheet (annual, 2024-06-30) — Common Stock: 148354600.00
IVX.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 14437672.00
IVX.AX balance_sheet (annual, 2024-06-30) — Current Assets: 2081171.00
IVX.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 1013815.00
IVX.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 816013.00
IVX.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 816013.00
IVX.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 19009.00
IVX.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 64244070.00
IVX.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.09
IVX.AX income_statement (annual, 2024-06-30) — EBIT: -5387765.00
IVX.AX income_statement (annual, 2024-06-30) — EBITDA: -4571752.00
IVX.AX cash_flow (annual, 2024-06-30) — End Cash Position: 783526.00
IVX.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -3301377.00
IVX.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 2163165.00
IVX.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 1506686.00
IVX.AX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 13330842.00
IVX.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 39474.00
IVX.AX income_statement (annual, 2024-06-30) — Gross Profit: 3694256.00
IVX.AX income_statement (annual, 2024-06-30) — Interest Expense: 240000.00
IVX.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 240000.00
IVX.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 63550.00
IVX.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 14437672.00
IVX.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -900000.00
IVX.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 39474.00
IVX.AX income_statement (annual, 2024-06-30) — Net Income: -5627765.00
IVX.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -5627765.00
IVX.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -5627765.00
IVX.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -5627765.00
IVX.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -5627765.00
IVX.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -5627765.00
IVX.AX cash_flow (annual, 2024-06-30) — Net Intangibles Purchase And Sale: -900000.00
IVX.AX income_statement (annual, 2024-06-30) — Net Interest Income: -240000.00
IVX.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -240000.00
IVX.AX balance_sheet (annual, 2024-06-30) — Net PPE: 39474.00
IVX.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 1106830.00
IVX.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -4571752.00
IVX.AX income_statement (annual, 2024-06-30) — Normalized Income: -5627765.00
IVX.AX income_statement (annual, 2024-06-30) — Operating Income: -5437202.00
IVX.AX income_statement (annual, 2024-06-30) — Operating Revenue: 3694256.00
IVX.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 66045322.00
IVX.AX balance_sheet (annual, 2024-06-30) — Other Current Assets: 87245.00
IVX.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 2163165.00
IVX.AX income_statement (annual, 2024-06-30) — Other Gand A: 670549.00
IVX.AX income_statement (annual, 2024-06-30) — Other Income Expense: 49437.00
IVX.AX balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 13330842.00
IVX.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 49437.00
IVX.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 421022.00
IVX.AX balance_sheet (annual, 2024-06-30) — Other Payable: 205713.00
IVX.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 1210400.00
IVX.AX balance_sheet (annual, 2024-06-30) — Payables: 926661.00
IVX.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 926661.00
IVX.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -4064927.00
IVX.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 87154.00
IVX.AX income_statement (annual, 2024-06-30) — Pretax Income: -5627765.00
IVX.AX income_statement (annual, 2024-06-30) — Provision For Doubtful Accounts: 3696720.00
IVX.AX cash_flow (annual, 2024-06-30) — Purchase Of Intangibles: -900000.00
IVX.AX cash_flow (annual, 2024-06-30) — Receiptsfrom Customers: 1600000.00
IVX.AX balance_sheet (annual, 2024-06-30) — Receivables: 1210400.00
IVX.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 816013.00
IVX.AX income_statement (annual, 2024-06-30) — Rent And Landing Fees: 14400.00
IVX.AX income_statement (annual, 2024-06-30) — Research And Development: 2691017.00
IVX.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -136080093.00
IVX.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 821737.00
IVX.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 1506686.00
IVX.AX balance_sheet (annual, 2024-06-30) — Share Issued: 66045322.00
IVX.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 14437672.00
IVX.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 1106830.00
IVX.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
IVX.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
IVX.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
IVX.AX balance_sheet (annual, 2024-06-30) — Total Assets: 15451487.00
IVX.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 14437672.00
IVX.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 14437672.00
IVX.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 1013815.00
IVX.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 13370316.00
IVX.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
IVX.AX balance_sheet (annual, 2024-06-30) — Working Capital: 1067356.00
IVX.AX income_statement (annual, 2025-06-30) — +Operating Expense: 8115972.00
IVX.AX balance_sheet (annual, 2025-06-30) — Accounts Payable: 542801.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 542801.00
IVX.AX income_statement (annual, 2025-06-30) — Amortization: 4795642.00
IVX.AX income_statement (annual, 2025-06-30) — Amortization Of Intangibles Income Statement: 4795642.00
IVX.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 72046984.00
IVX.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.12
IVX.AX cash_flow (annual, 2025-06-30) — Beginning Cash Position: 783526.00
IVX.AX balance_sheet (annual, 2025-06-30) — Capital Stock: 151206865.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 151206865.00
IVX.AX balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 850373.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 850373.00
IVX.AX balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 850373.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 850373.00
IVX.AX balance_sheet (annual, 2025-06-30) — Cash Financial: 850373.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 850373.00
IVX.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: 3035692.00
IVX.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
IVX.AX cash_flow (annual, 2025-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2968845.00
IVX.AX cash_flow (annual, 2025-06-30) — Changes In Cash: 66847.00
IVX.AX cash_flow (annual, 2025-06-30) — Classesof Cash Payments: -2971860.00
IVX.AX balance_sheet (annual, 2025-06-30) — Common Stock: 151206865.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Common Stock: 151206865.00
IVX.AX balance_sheet (annual, 2025-06-30) — Common Stock Equity: 8250751.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 8250751.00
IVX.AX cash_flow (annual, 2025-06-30) — Common Stock Issuance: 3950400.00
IVX.AX cash_flow (annual, 2025-06-30) — Common Stock Payments: -170302.00
IVX.AX balance_sheet (annual, 2025-06-30) — Current Assets: 933203.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Current Assets: 933203.00
IVX.AX balance_sheet (annual, 2025-06-30) — Current Liabilities: 1238168.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1238168.00
IVX.AX income_statement (annual, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 4814600.00
IVX.AX income_statement (annual, 2025-06-30) — Depreciation And Amortization In Income Statement: 4814600.00
IVX.AX income_statement (annual, 2025-06-30) — Depreciation Income Statement: 18958.00
IVX.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 72046984.00
IVX.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.12
IVX.AX income_statement (annual, 2025-06-30) — EBIT: -8112957.00
IVX.AX income_statement (annual, 2025-06-30) — EBITDA: -3298357.00
IVX.AX cash_flow (annual, 2025-06-30) — End Cash Position: 850373.00
IVX.AX cash_flow (annual, 2025-06-30) — Financing Cash Flow: 3035692.00
IVX.AX cash_flow (annual, 2025-06-30) — Free Cash Flow: -2968845.00
IVX.AX balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1585276.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1585276.00
IVX.AX income_statement (annual, 2025-06-30) — General And Administrative Expense: 1556287.00
IVX.AX balance_sheet (annual, 2025-06-30) — Goodwill And Other Intangible Assets: 8535200.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 8535200.00
IVX.AX balance_sheet (annual, 2025-06-30) — Gross PPE: 20516.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 20516.00
IVX.AX income_statement (annual, 2025-06-30) — Interest Expense: 694775.00
IVX.AX income_statement (annual, 2025-06-30) — Interest Expense Non Operating: 694775.00
IVX.AX cash_flow (annual, 2025-06-30) — Interest Received Direct: 3015.00
IVX.AX balance_sheet (annual, 2025-06-30) — Invested Capital: 8250751.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 8250751.00
IVX.AX cash_flow (annual, 2025-06-30) — Investing Cash Flow: 0.00
IVX.AX cash_flow (annual, 2025-06-30) — Issuance Of Capital Stock: 3950400.00
IVX.AX cash_flow (annual, 2025-06-30) — Long Term Debt Payments: -744406.00
IVX.AX balance_sheet (annual, 2025-06-30) — Machinery Furniture Equipment: 20516.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 20516.00
IVX.AX cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: 3780098.00
IVX.AX income_statement (annual, 2025-06-30) — Net Income: -8807732.00
IVX.AX income_statement (annual, 2025-06-30) — Net Income Common Stockholders: -8807732.00
IVX.AX income_statement (annual, 2025-06-30) — Net Income Continuous Operations: -8807732.00
IVX.AX income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -8807732.00
IVX.AX income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -8807732.00
IVX.AX income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: -8807732.00
IVX.AX income_statement (annual, 2025-06-30) — Net Interest Income: -694775.00
IVX.AX cash_flow (annual, 2025-06-30) — Net Issuance Payments Of Debt: -744406.00
IVX.AX cash_flow (annual, 2025-06-30) — Net Long Term Debt Issuance: -744406.00
IVX.AX income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: -694775.00
IVX.AX balance_sheet (annual, 2025-06-30) — Net PPE: 20516.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Net PPE: 20516.00
IVX.AX balance_sheet (annual, 2025-06-30) — Net Tangible Assets: -284449.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -284449.00
IVX.AX income_statement (annual, 2025-06-30) — Normalized EBITDA: -3298357.00
IVX.AX income_statement (annual, 2025-06-30) — Normalized Income: -8807732.00
IVX.AX income_statement (annual, 2025-06-30) — Operating Income: -8115972.00
IVX.AX balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 84875801.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 84875801.00
IVX.AX balance_sheet (annual, 2025-06-30) — Other Current Assets: 82830.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 82830.00
IVX.AX balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: 1585276.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1585276.00
IVX.AX income_statement (annual, 2025-06-30) — Other Gand A: 869751.00
IVX.AX income_statement (annual, 2025-06-30) — Other Income Expense: 3015.00
IVX.AX balance_sheet (annual, 2025-06-30) — Other Intangible Assets: 8535200.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 8535200.00
IVX.AX income_statement (annual, 2025-06-30) — Other Non Operating Income Expenses: 3015.00
IVX.AX income_statement (annual, 2025-06-30) — Other Operating Expenses: 454800.00
IVX.AX balance_sheet (annual, 2025-06-30) — Other Payable: 584444.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Other Payable: 584444.00
IVX.AX balance_sheet (annual, 2025-06-30) — Payables: 1127245.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Payables: 1127245.00
IVX.AX balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 1127245.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1127245.00
IVX.AX cash_flow (annual, 2025-06-30) — Paymentsto Suppliersfor Goodsand Services: -2971860.00
IVX.AX balance_sheet (annual, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 110923.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 110923.00
IVX.AX income_statement (annual, 2025-06-30) — Pretax Income: -8807732.00
IVX.AX income_statement (annual, 2025-06-30) — Reconciled Depreciation: 4814600.00
IVX.AX cash_flow (annual, 2025-06-30) — Repayment Of Debt: -744406.00
IVX.AX cash_flow (annual, 2025-06-30) — Repurchase Of Capital Stock: -170302.00
IVX.AX income_statement (annual, 2025-06-30) — Research And Development: 1290285.00
IVX.AX balance_sheet (annual, 2025-06-30) — Retained Earnings: -144541390.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -144541390.00
IVX.AX income_statement (annual, 2025-06-30) — Salaries And Wages: 686536.00
IVX.AX income_statement (annual, 2025-06-30) — Selling General And Administration: 1556287.00
IVX.AX balance_sheet (annual, 2025-06-30) — Share Issued: 84875801.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 84875801.00
IVX.AX balance_sheet (annual, 2025-06-30) — Stockholders Equity: 8250751.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 8250751.00
IVX.AX balance_sheet (annual, 2025-06-30) — Tangible Book Value: -284449.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -284449.00
IVX.AX income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IVX.AX income_statement (annual, 2025-06-30) — Tax Provision: 0.00
IVX.AX income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.00
IVX.AX balance_sheet (annual, 2025-06-30) — Total Assets: 9488919.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 9488919.00
IVX.AX balance_sheet (annual, 2025-06-30) — Total Capitalization: 8250751.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 8250751.00
IVX.AX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 8250751.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 8250751.00
IVX.AX balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 1238168.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1238168.00
IVX.AX balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 8555716.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 8555716.00
IVX.AX balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
IVX.AX balance_sheet (annual, 2025-06-30) — Working Capital: -304965.00
IVX.AX balance_sheet (quarterly, 2025-06-30) — Working Capital: -304965.00
IVX.V cash_flow (annual, 2021-12-31) — Change In Account Payable: 572000.00
IVX.V cash_flow (annual, 2021-12-31) — Change In Income Tax Payable: 0.00
IVX.V cash_flow (annual, 2021-12-31) — Change In Tax Payable: 0.00
IVX.V cash_flow (annual, 2021-12-31) — Common Stock Issuance: 46000.00
IVX.V balance_sheet (annual, 2021-12-31) — Construction In Progress: 3000.00
IVX.V cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 46000.00
IVX.V cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 46000.00
IVX.V cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -36000.00
IVX.V balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 511000.00
IVX.V balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 511000.00
IVX.V balance_sheet (annual, 2021-12-31) — Other Receivables: 6000.00
IVX.V cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 46000.00
IVX.V income_statement (annual, 2022-12-31) — +Operating Expense: 1078000.00
IVX.V income_statement (annual, 2022-12-31) — +Total Revenue: 14245000.00
IVX.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 619000.00
IVX.V balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1264000.00
IVX.V balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -8534000.00
IVX.V balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 298000.00
IVX.V income_statement (annual, 2022-12-31) — Basic Average Shares: 4817565.00
IVX.V income_statement (annual, 2022-12-31) — Basic EPS: 0.43
IVX.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 216000.00
IVX.V balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 2106000.00
IVX.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -327000.00
IVX.V balance_sheet (annual, 2022-12-31) — Capital Stock: 1266000.00
IVX.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 379000.00
IVX.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 379000.00
IVX.V cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -1694000.00
IVX.V balance_sheet (annual, 2022-12-31) — Cash Financial: 379000.00
IVX.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -1805000.00
IVX.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -327000.00
IVX.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 2295000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Account Payable: -66000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 310000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Inventory: -532000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -10000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 310000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Payable: -66000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -66000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Receivables: -412000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Tax Payable: 310000.00
IVX.V cash_flow (annual, 2022-12-31) — Change In Working Capital: -710000.00
IVX.V cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -412000.00
IVX.V cash_flow (annual, 2022-12-31) — Changes In Cash: 163000.00
IVX.V balance_sheet (annual, 2022-12-31) — Common Stock: 1266000.00
IVX.V cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -1694000.00
IVX.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2892000.00
IVX.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 55000.00
IVX.V balance_sheet (annual, 2022-12-31) — Construction In Progress: 126000.00
IVX.V income_statement (annual, 2022-12-31) — Cost Of Revenue: 10125000.00
IVX.V balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 150000.00
IVX.V balance_sheet (annual, 2022-12-31) — Current Assets: 3536000.00
IVX.V balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 58000.00
IVX.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 1142000.00
IVX.V cash_flow (annual, 2022-12-31) — Deferred Income Tax: 515000.00
IVX.V cash_flow (annual, 2022-12-31) — Deferred Tax: 515000.00
IVX.V cash_flow (annual, 2022-12-31) — Depreciation: 134000.00
IVX.V cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 134000.00
IVX.V cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 134000.00
IVX.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 4967826.00
IVX.V income_statement (annual, 2022-12-31) — Diluted EPS: 0.42
IVX.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 2093000.00
IVX.V income_statement (annual, 2022-12-31) — EBIT: 3042000.00
IVX.V income_statement (annual, 2022-12-31) — EBITDA: 3176000.00
IVX.V cash_flow (annual, 2022-12-31) — End Cash Position: 379000.00
IVX.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: -1805000.00
IVX.V balance_sheet (annual, 2022-12-31) — Finished Goods: 306000.00
IVX.V cash_flow (annual, 2022-12-31) — Free Cash Flow: 1968000.00
IVX.V balance_sheet (annual, 2022-12-31) — Gross PPE: 11025000.00
IVX.V income_statement (annual, 2022-12-31) — Gross Profit: 4120000.00
IVX.V balance_sheet (annual, 2022-12-31) — Income Tax Payable: 310000.00
IVX.V income_statement (annual, 2022-12-31) — Interest Expense: 114000.00
IVX.V income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 114000.00
IVX.V cash_flow (annual, 2022-12-31) — Interest Paid Cff: -112000.00
IVX.V balance_sheet (annual, 2022-12-31) — Inventory: 1856000.00
IVX.V balance_sheet (annual, 2022-12-31) — Invested Capital: 4881000.00
IVX.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -327000.00
IVX.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 55000.00
IVX.V cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
IVX.V balance_sheet (annual, 2022-12-31) — Land And Improvements: 6000.00
IVX.V balance_sheet (annual, 2022-12-31) — Long Term Debt: 1989000.00
IVX.V balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1989000.00
IVX.V cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
IVX.V cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -54000.00
IVX.V balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 8787000.00
IVX.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 55000.00
IVX.V balance_sheet (annual, 2022-12-31) — Net Debt: 1610000.00
IVX.V income_statement (annual, 2022-12-31) — Net Income: 2093000.00
IVX.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 2093000.00
IVX.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 2093000.00
IVX.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 2093000.00
IVX.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 2093000.00
IVX.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 2093000.00
IVX.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 2093000.00
IVX.V income_statement (annual, 2022-12-31) — Net Interest Income: -114000.00
IVX.V cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -54000.00
IVX.V cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -54000.00
IVX.V income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -114000.00
IVX.V balance_sheet (annual, 2022-12-31) — Net PPE: 2491000.00
IVX.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -327000.00
IVX.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2892000.00
IVX.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 0.00
IVX.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4000.00
IVX.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 0.00
IVX.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4000.00
IVX.V income_statement (annual, 2022-12-31) — Normalized EBITDA: 3176000.00
IVX.V income_statement (annual, 2022-12-31) — Normalized Income: 2093000.00
IVX.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: 2295000.00
IVX.V income_statement (annual, 2022-12-31) — Operating Income: 3042000.00
IVX.V income_statement (annual, 2022-12-31) — Operating Revenue: 14245000.00
IVX.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 4838145.00
IVX.V balance_sheet (annual, 2022-12-31) — Other Current Assets: 37000.00
IVX.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: 263000.00
IVX.V balance_sheet (annual, 2022-12-31) — Other Payable: 5000.00
IVX.V balance_sheet (annual, 2022-12-31) — Payables: 934000.00
IVX.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1084000.00
IVX.V income_statement (annual, 2022-12-31) — Pretax Income: 2928000.00
IVX.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -327000.00
IVX.V balance_sheet (annual, 2022-12-31) — Raw Materials: 1530000.00
IVX.V balance_sheet (annual, 2022-12-31) — Receivables: 1264000.00
IVX.V income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 10125000.00
IVX.V income_statement (annual, 2022-12-31) — Reconciled Depreciation: 134000.00
IVX.V cash_flow (annual, 2022-12-31) — Repayment Of Debt: -54000.00
IVX.V balance_sheet (annual, 2022-12-31) — Retained Earnings: 1328000.00
IVX.V income_statement (annual, 2022-12-31) — Selling General And Administration: 1078000.00
IVX.V balance_sheet (annual, 2022-12-31) — Share Issued: 4838145.00
IVX.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2892000.00
IVX.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2892000.00
IVX.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
IVX.V income_statement (annual, 2022-12-31) — Tax Provision: 835000.00
IVX.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.29
IVX.V balance_sheet (annual, 2022-12-31) — Taxes Receivable: 0.00
IVX.V balance_sheet (annual, 2022-12-31) — Total Assets: 6027000.00
IVX.V balance_sheet (annual, 2022-12-31) — Total Capitalization: 4881000.00
IVX.V balance_sheet (annual, 2022-12-31) — Total Debt: 2047000.00
IVX.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2892000.00
IVX.V income_statement (annual, 2022-12-31) — Total Expenses: 11203000.00
IVX.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3135000.00
IVX.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 2491000.00
IVX.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1993000.00
IVX.V balance_sheet (annual, 2022-12-31) — Total Tax Payable: 310000.00
IVX.V balance_sheet (annual, 2022-12-31) — Work In Process: 20000.00
IVX.V balance_sheet (annual, 2022-12-31) — Working Capital: 2394000.00
IVX.V income_statement (annual, 2023-12-31) — +Operating Expense: 1032000.00
IVX.V income_statement (annual, 2023-12-31) — +Total Revenue: 8859000.00
IVX.V balance_sheet (annual, 2023-12-31) — Accounts Payable: 227000.00
IVX.V balance_sheet (annual, 2023-12-31) — Accounts Receivable: 574000.00
IVX.V balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -8028000.00
IVX.V balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 364000.00
IVX.V income_statement (annual, 2023-12-31) — Basic Average Shares: 4865796.00
IVX.V income_statement (annual, 2023-12-31) — Basic EPS: 0.08
IVX.V cash_flow (annual, 2023-12-31) — Beginning Cash Position: 379000.00
IVX.V balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 2396000.00
IVX.V cash_flow (annual, 2023-12-31) — Capital Expenditure: -931000.00
IVX.V balance_sheet (annual, 2023-12-31) — Capital Stock: 1337000.00
IVX.V balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 933000.00
IVX.V balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 933000.00
IVX.V cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -584000.00
IVX.V balance_sheet (annual, 2023-12-31) — Cash Financial: 933000.00
IVX.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -82000.00
IVX.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -931000.00
IVX.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 1567000.00
IVX.V cash_flow (annual, 2023-12-31) — Change In Inventory: 836000.00
IVX.V cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 4000.00
IVX.V cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -611000.00
IVX.V cash_flow (annual, 2023-12-31) — Change In Payable: -341000.00
IVX.V cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -341000.00
IVX.V cash_flow (annual, 2023-12-31) — Change In Receivables: 690000.00
IVX.V cash_flow (annual, 2023-12-31) — Change In Working Capital: 578000.00
IVX.V cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 690000.00
IVX.V cash_flow (annual, 2023-12-31) — Changes In Cash: 554000.00
IVX.V balance_sheet (annual, 2023-12-31) — Common Stock: 1337000.00
IVX.V cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -584000.00
IVX.V balance_sheet (annual, 2023-12-31) — Common Stock Equity: 2814000.00
IVX.V cash_flow (annual, 2023-12-31) — Common Stock Issuance: 55000.00
IVX.V balance_sheet (annual, 2023-12-31) — Construction In Progress: 0.00
IVX.V income_statement (annual, 2023-12-31) — Cost Of Revenue: 7163000.00
IVX.V balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 190000.00
IVX.V balance_sheet (annual, 2023-12-31) — Current Assets: 2861000.00
IVX.V balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 174000.00
IVX.V balance_sheet (annual, 2023-12-31) — Current Liabilities: 607000.00
IVX.V cash_flow (annual, 2023-12-31) — Deferred Income Tax: 233000.00
IVX.V cash_flow (annual, 2023-12-31) — Deferred Tax: 233000.00
IVX.V cash_flow (annual, 2023-12-31) — Depreciation: 188000.00
IVX.V cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 188000.00
IVX.V cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 188000.00
IVX.V income_statement (annual, 2023-12-31) — Diluted Average Shares: 4969158.00
IVX.V income_statement (annual, 2023-12-31) — Diluted EPS: 0.07
IVX.V income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 369000.00
IVX.V income_statement (annual, 2023-12-31) — EBIT: 664000.00
IVX.V income_statement (annual, 2023-12-31) — EBITDA: 852000.00
IVX.V cash_flow (annual, 2023-12-31) — End Cash Position: 933000.00
IVX.V cash_flow (annual, 2023-12-31) — Financing Cash Flow: -82000.00
IVX.V balance_sheet (annual, 2023-12-31) — Finished Goods: 30000.00
IVX.V cash_flow (annual, 2023-12-31) — Free Cash Flow: 636000.00
IVX.V balance_sheet (annual, 2023-12-31) — Gross PPE: 11262000.00
IVX.V income_statement (annual, 2023-12-31) — Gross Profit: 1696000.00
IVX.V balance_sheet (annual, 2023-12-31) — Income Tax Payable: 0.00
IVX.V income_statement (annual, 2023-12-31) — Interest Expense: 117000.00
IVX.V income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 117000.00
IVX.V cash_flow (annual, 2023-12-31) — Interest Paid Cff: -117000.00
IVX.V balance_sheet (annual, 2023-12-31) — Inventory: 1020000.00
IVX.V balance_sheet (annual, 2023-12-31) — Invested Capital: 5251000.00
IVX.V cash_flow (annual, 2023-12-31) — Investing Cash Flow: -931000.00
IVX.V cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 55000.00
IVX.V cash_flow (annual, 2023-12-31) — Issuance Of Debt: 650000.00
IVX.V balance_sheet (annual, 2023-12-31) — Land And Improvements: 6000.00
IVX.V balance_sheet (annual, 2023-12-31) — Long Term Debt: 2437000.00
IVX.V balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2437000.00
IVX.V cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 650000.00
IVX.V cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -86000.00
IVX.V balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 8860000.00
IVX.V cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 55000.00
IVX.V balance_sheet (annual, 2023-12-31) — Net Debt: 1504000.00
IVX.V income_statement (annual, 2023-12-31) — Net Income: 369000.00
IVX.V income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 369000.00
IVX.V income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 369000.00
IVX.V income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 369000.00
IVX.V income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 369000.00
IVX.V cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 369000.00
IVX.V income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 369000.00
IVX.V income_statement (annual, 2023-12-31) — Net Interest Income: -117000.00
IVX.V cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 564000.00
IVX.V cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 564000.00
IVX.V income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -117000.00
IVX.V balance_sheet (annual, 2023-12-31) — Net PPE: 3234000.00
IVX.V cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -931000.00
IVX.V balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 2814000.00
IVX.V balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 237000.00
IVX.V balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 237000.00
IVX.V income_statement (annual, 2023-12-31) — Normalized EBITDA: 852000.00
IVX.V income_statement (annual, 2023-12-31) — Normalized Income: 369000.00
IVX.V cash_flow (annual, 2023-12-31) — Operating Cash Flow: 1567000.00
IVX.V income_statement (annual, 2023-12-31) — Operating Income: 664000.00
IVX.V income_statement (annual, 2023-12-31) — Operating Revenue: 8859000.00
IVX.V balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 4871145.00
IVX.V balance_sheet (annual, 2023-12-31) — Other Current Assets: 33000.00
IVX.V cash_flow (annual, 2023-12-31) — Other Non Cash Items: 199000.00
IVX.V balance_sheet (annual, 2023-12-31) — Other Payable: 16000.00
IVX.V balance_sheet (annual, 2023-12-31) — Payables: 243000.00
IVX.V balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 433000.00
IVX.V income_statement (annual, 2023-12-31) — Pretax Income: 547000.00
IVX.V cash_flow (annual, 2023-12-31) — Purchase Of PPE: -931000.00
IVX.V balance_sheet (annual, 2023-12-31) — Raw Materials: 963000.00
IVX.V balance_sheet (annual, 2023-12-31) — Receivables: 875000.00
IVX.V income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 7163000.00
IVX.V income_statement (annual, 2023-12-31) — Reconciled Depreciation: 188000.00
IVX.V cash_flow (annual, 2023-12-31) — Repayment Of Debt: -86000.00
IVX.V balance_sheet (annual, 2023-12-31) — Retained Earnings: 1113000.00
IVX.V income_statement (annual, 2023-12-31) — Selling General And Administration: 1032000.00
IVX.V balance_sheet (annual, 2023-12-31) — Share Issued: 4871145.00
IVX.V balance_sheet (annual, 2023-12-31) — Stockholders Equity: 2814000.00
IVX.V balance_sheet (annual, 2023-12-31) — Tangible Book Value: 2814000.00
IVX.V income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
IVX.V income_statement (annual, 2023-12-31) — Tax Provision: 178000.00
IVX.V income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.33
IVX.V balance_sheet (annual, 2023-12-31) — Taxes Receivable: 301000.00
IVX.V balance_sheet (annual, 2023-12-31) — Total Assets: 6095000.00
IVX.V balance_sheet (annual, 2023-12-31) — Total Capitalization: 5251000.00
IVX.V balance_sheet (annual, 2023-12-31) — Total Debt: 2611000.00
IVX.V balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 2814000.00
IVX.V income_statement (annual, 2023-12-31) — Total Expenses: 8195000.00
IVX.V balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3281000.00
IVX.V balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3234000.00
IVX.V balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2674000.00
IVX.V balance_sheet (annual, 2023-12-31) — Total Tax Payable: 0.00
IVX.V balance_sheet (annual, 2023-12-31) — Work In Process: 27000.00
IVX.V balance_sheet (annual, 2023-12-31) — Working Capital: 2254000.00
IVX.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 4871145.00
IVX.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.01
IVX.V cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: 167000.00
IVX.V cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: 0.00
IVX.V cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
IVX.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 4871145.00
IVX.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.01
IVX.V income_statement (quarterly, 2024-09-30) — Gross Profit: 209000.00
IVX.V cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
IVX.V cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
IVX.V cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
IVX.V cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
IVX.V income_statement (annual, 2024-12-31) — +Operating Expense: 909000.00
IVX.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 421000.00
IVX.V income_statement (annual, 2024-12-31) — +Total Revenue: 6309000.00
IVX.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 1328000.00
IVX.V balance_sheet (annual, 2024-12-31) — Accounts Payable: 462000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 462000.00
IVX.V balance_sheet (annual, 2024-12-31) — Accounts Receivable: 536000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 536000.00
IVX.V balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -7969000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -7969000.00
IVX.V balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 366000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 366000.00
IVX.V balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
IVX.V income_statement (annual, 2024-12-31) — Basic Average Shares: 4871145.00
IVX.V income_statement (annual, 2024-12-31) — Basic EPS: -0.01
IVX.V cash_flow (annual, 2024-12-31) — Beginning Cash Position: 933000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 888000.00
IVX.V balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 2416000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 2416000.00
IVX.V cash_flow (annual, 2024-12-31) — Capital Expenditure: -213000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -27000.00
IVX.V balance_sheet (annual, 2024-12-31) — Capital Stock: 1337000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 1337000.00
IVX.V balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 836000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 836000.00
IVX.V balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 836000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 836000.00
IVX.V cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -487000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
IVX.V balance_sheet (annual, 2024-12-31) — Cash Financial: 836000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Cash Financial: 836000.00
IVX.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -808000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -84000.00
IVX.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -213000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -27000.00
IVX.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 924000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: 59000.00
IVX.V cash_flow (annual, 2024-12-31) — Change In Inventory: 54000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Change In Inventory: -159000.00
IVX.V cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 2000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 26000.00
IVX.V cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 201000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -152000.00
IVX.V cash_flow (annual, 2024-12-31) — Change In Payable: 314000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Change In Payable: 68000.00
IVX.V cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 314000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 68000.00
IVX.V cash_flow (annual, 2024-12-31) — Change In Receivables: 38000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: 401000.00
IVX.V cash_flow (annual, 2024-12-31) — Change In Working Capital: 609000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 184000.00
IVX.V cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 38000.00
IVX.V cash_flow (annual, 2024-12-31) — Changes In Cash: -97000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: -52000.00
IVX.V balance_sheet (annual, 2024-12-31) — Common Stock: 1337000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 1337000.00
IVX.V cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -487000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: 0.00
IVX.V balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2267000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 2267000.00
IVX.V cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
IVX.V cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
IVX.V income_statement (annual, 2024-12-31) — Cost Of Revenue: 5356000.00
IVX.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 1193000.00
IVX.V balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 282000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 282000.00
IVX.V balance_sheet (annual, 2024-12-31) — Current Assets: 2469000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 2469000.00
IVX.V balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 186000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 186000.00
IVX.V balance_sheet (annual, 2024-12-31) — Current Liabilities: 933000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 933000.00
IVX.V cash_flow (annual, 2024-12-31) — Deferred Income Tax: 26000.00
IVX.V cash_flow (annual, 2024-12-31) — Deferred Tax: 26000.00
IVX.V cash_flow (annual, 2024-12-31) — Depreciation: 203000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Depreciation: 51000.00
IVX.V cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 203000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 51000.00
IVX.V cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 203000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 51000.00